Stock Price
12.56
Daily Change
-0.02 -0.16%
Monthly
-12.72%
Yearly
-70.38%
Q3 Forecast
12.48

Tandem Diabetes Care reported $133.28M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.



Financials
Assets USD 875.74M
Cost of Sales USD 114.82M
Current Assets USD 614.82M
Debt USD 449.01M
EBIT USD -31.86M
EBITDA USD -1.85M
Employees 2.65K
Interest Income USD 4.19M
Loan Capital USD 309.15M
Net Income USD -52.4M
Operating Expenses USD 272.54M
Operating Profit USD -31.86M
Pre-Tax Profit USD -57.72M
Sales Revenues USD 240.68M
Stock USD 142.57M
Trade Creditors USD 55.84M
Trade Debtors USD 128.44M

Equity Capital And Reserves Change Date
Abbott USD 50.83B 1.76B Jun/2025
Align Technology USD 3.79B 57.74M Mar/2025
AtriCure USD 464.49M 9.87M Jun/2025
Baxter International USD 7.05B 90M Mar/2025
Becton, Dickinson and Co. USD 25.47B 231M Jun/2025
Boston Scientific USD 22.21B 443M Mar/2025
Cooper Companies USD 8.35B 64.9M Jul/2025
Dexcom USD 2.57B 306.5M Jun/2025
Edwards Lifesciences USD 10.19B 193.2M Mar/2025
Eli Lilly USD 18.27B 2.43B Jun/2025
Globus Medical USD 4.3B 207.61M Jun/2025
ICU Medical USD 2.12B 128.09M Jun/2025
Insulet USD 1.46B 132.2M Jun/2025
Integra LifeSciences USD 1.04B 485.48M Jun/2025
Intuitive Surgical USD 17.95B 745.4M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Masimo USD 1.04B 96.4M Jun/2025
Medtronic USD 48.02B 1.36B Apr/2025
Merit Medical Systems USD 1.49B 59.62M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Stryker USD 21.19B 261M Jun/2025
Tandem Diabetes Care USD 133.28M 22.01M Jun/2025
Teleflex USD 4.24B 147.7M Jun/2025
Zimmer Biomet Holdings USD 12.53B 130.5M Jun/2025